Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice (Q45754233)

15 December 2017

title

Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice (English)

1 reference

15 December 2017

author name string

Kostense S

1

1 reference

15 December 2017

Sun WH

2

1 reference

15 December 2017

Cottey R

3

1 reference

15 December 2017

Taylor SF

4

1 reference

15 December 2017

Harmeling S

5

1 reference

15 December 2017

Zander D

6

1 reference

15 December 2017

Small PA Jr

7

1 reference

15 December 2017

Bender BS

8

1 reference

15 December 2017

publication date

1 May 1998

1 reference

15 December 2017

published in

Antiviral Research

1 reference

15 December 2017

volume

38

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

117-130

1 reference

15 December 2017

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Heterotypic immune mice lose protection against influenza virus infection with senescence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Interleukin-12: potential clinical applications in the treatment and prevention of infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

In vivo augmentation of IFN-gamma with a rIL-12 human/mouse chimera: pleiotropic effects against infectious agents in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Enteric immunization of mice against influenza with recombinant vaccinia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

IL-12: initiation cytokine for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

The role of interleukin 12 in the immune response, disease and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

Immunoglobulin isotype modulation after administration of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900019-9

7 January 2021

10.1016/S0166-3542(98)00019-9

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017